Gujarat Themis Biosyn (BOM:506879) E10: ₹3.38 (As of Mar. 2026)


BOM:506879 Gujarat Themis Biosyn Ltd BOM:506879
76 GF Score
Price ₹385.20
GF Value ₹313.15
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Gujarat Themis Biosyn E10?

Gujarat Themis Biosyn BOM:506879 -0.28% 76 E10 is ₹3.38 as of Mar. 2026. GuruFocus rates BOM:506879 with a GF Score™ of 76/100 and a GF Value™ of ₹313.15 (Modestly Overvalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Gujarat Themis Biosyn's adjusted earnings per share data for the three months ended in Mar. 2026 was ₹1.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹3.38 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Gujarat Themis Biosyn's average E10 Growth Rate was 17.00% per year. During the past 3 years, the average E10 Growth Rate was 21.40% per year. During the past 5 years, the average E10 Growth Rate was 29.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Gujarat Themis Biosyn was 36.00% per year. The lowest was 21.40% per year. And the median was 30.80% per year.

As of today (2026-07-07), Gujarat Themis Biosyn's current stock price is ₹385.20. Gujarat Themis Biosyn's E10 for the quarter that ended in Mar. 2026 was ₹3.38. Gujarat Themis Biosyn's Shiller PE Ratio of today is 113.96.

During the past 13 years, the highest Shiller PE Ratio of Gujarat Themis Biosyn was 146.53. The lowest was 28.82. And the median was 60.35.


Gujarat Themis Biosyn  (BOM:506879) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Gujarat Themis Biosyn's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=385.20/3.38
=113.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Gujarat Themis Biosyn was 146.53. The lowest was 28.82. And the median was 60.35.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Gujarat Themis Biosyn E10 Related Terms


Gujarat Themis Biosyn E10 Historical Data

* Premium members only.

The historical data trend for Gujarat Themis Biosyn's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gujarat Themis Biosyn E10 Chart

Gujarat Themis Biosyn Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.29 1.89 2.44 2.89 3.38

Gujarat Themis Biosyn Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.89 3.00 3.16 3.28 3.38

BOM:506879 vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Gujarat Themis Biosyn's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gujarat Themis Biosyn Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gujarat Themis Biosyn's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Gujarat Themis Biosyn's Shiller PE Ratio falls into.


BOM:506879
76GF Score
Gujarat Themis Biosyn Ltd BOM:506879
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gujarat Themis Biosyn E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Gujarat Themis Biosyn's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1/164.2724*164.2724
=1.000

Current CPI (Mar. 2026) = 164.2724.

Gujarat Themis Biosyn Quarterly Data

per share eps CPI Adj_EPS
201606 0.120 105.961 0.186
201609 0.001 105.961 0.002
201612 0.001 105.196 0.002
201703 0.111 105.196 0.173
201706 0.084 107.109 0.129
201709 0.083 109.021 0.125
201712 0.091 109.404 0.137
201803 0.092 109.786 0.138
201806 0.123 111.317 0.182
201809 0.123 115.142 0.175
201812 0.112 115.142 0.160
201903 0.231 118.202 0.321
201906 0.129 120.880 0.175
201909 0.147 123.175 0.196
201912 0.891 126.235 1.159
202003 1.005 124.705 1.324
202006 0.512 127.000 0.662
202009 1.041 130.118 1.314
202012 0.685 130.889 0.860
202103 0.531 131.771 0.662
202106 1.185 134.084 1.452
202109 1.265 135.847 1.530
202112 0.653 138.161 0.776
202203 0.899 138.822 1.064
202206 1.631 142.347 1.882
202209 1.716 144.661 1.949
202212 0.900 145.763 1.014
202303 1.073 146.865 1.200
202306 1.627 150.280 1.778
202309 1.150 151.492 1.247
202312 1.190 152.924 1.278
202403 1.460 153.035 1.567
202406 1.210 155.789 1.276
202409 0.970 157.882 1.009
202412 1.190 158.323 1.235
202503 1.100 157.552 1.147
202506 0.830 159.755 0.853
202509 1.310 162.289 1.326
202512 1.140 163.281 1.147
202603 1.000 164.272 1.000

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹3.38 mean?
Gujarat Themis Biosyn (BOM:506879) has a E10 of ₹3.38 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Gujarat Themis Biosyn and its competitors.
Is Gujarat Themis Biosyn's E10 too high?
Gujarat Themis Biosyn's current E10 is ₹3.38. Overall, Gujarat Themis Biosyn has a GF Score™ of 76/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Gujarat Themis Biosyn's E10 compare to ZTS and UTHR?
Gujarat Themis Biosyn's E10 of ₹3.38 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Gujarat Themis Biosyn and its competitors. Gujarat Themis Biosyn's current E10 is ₹3.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gujarat Themis Biosyn stock overvalued right now?
Based on GuruFocus' analysis, Gujarat Themis Biosyn (BOM:506879) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹313.15, compared to a current price of ₹385.20 — trading 23% above its estimated fair value. The current E10 is ₹3.38. Gujarat Themis Biosyn's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Gujarat Themis Biosyn (BOM:506879), the current E10 is ₹3.38 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gujarat Themis Biosyn (BOM:506879) Overvalued in 2026?

Based on GuruFocus' analysis, Gujarat Themis Biosyn stock appears to be overvalued. The current stock price of ₹385.20 is trading 23% above its estimated GF Value™ of ₹313.15. GuruFocus considers Gujarat Themis Biosyn to be Modestly Overvalued.

Key valuation signals for BOM:506879:

  • E10: ₹3.38
  • GF Value™: ₹313.15 vs. price of ₹385.20 (23% above fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the BOM:506879 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Gujarat Themis Biosyn Business Description

Other Exchanges GUJTHEM:India
Address S.V Road, Themis House, 11/12 Udyog Nagar, Goregaon (West), Mumbai, MH, IND, 400104
Gujarat Themis Biosyn Ltd is engaged in manufacturing, exporting, and selling of bulk drugs on a job-work basis. The company operates in one segment which is pharmaceuticals. Its products include Rifamycin-S, which is an intermediate for Rifampicin for the treatment of tuberculosis (TB), and Lovastatin.
76GF Score

Get the complete analysis for BOM:506879

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹385.20
Price
₹313.15
GF Value